UPCOMING EVENTS
UPCOMING EVENTS
ASH Friday Satellite Symposia
Bringing Emerging Treatments to All Patients
December 5, 2025
A 3-hour symposium with presentations for community oncologists, preceding the ASH Annual Meeting.
Innovative immune effector therapies, including CAR T-cell and bi-specific antibody treatments, have transformed cancer care but remain largely inaccessible to community oncology practices. Our NETWORK is dedicated to bridging this gap by establishing the necessary infrastructure, protocols, and training to safely and effectively administer these lifesaving therapies in community settings. By promoting equitable access, fostering clinical trial participation, and supporting diverse patient populations, we aim to reduce disparities and expand the reach of modern cellular therapies.
Reaching Clinical Trial Excellence
December 5, 2025
This symposium convenes oncology professionals, researchers, and policy advocates to explore the current challenges and strategic solutions in advancing inclusive excellence across the cancer research continuum. Attendees will engage with thought leaders discussing policy-aligned models for accountability, tools for building diversity plans into clinical trial design, and methods for standardizing demographic reporting in academic publications.
With a focus on practical implementation, the DRIVE Initiative offers a blueprint to help institutions, sponsors, and investigators align with regulatory guidance, such as the U.S. FDORA Act of 2022, while advocating for its broader international adoption. This is more than an academic discussion; it's a call to action for stakeholders committed to advancing equitable outcomes in cancer care and research.
Quarterly Dinner
Indy Hematology Clinical Rounds
January 21, 2026
In pursuant of promoting education in hematologic malignancies and disorders, Dr. Ruemu Ejedafeta Birhiray, President and CEO of Indy Hematology Education, Inc, in collaboration with Dr’s. Sumeet Bhatia and Catherine Socec, co- chair “Indy Hematology Clinical Rounds®” a quarterly CME education program.
This program is to create a tumor board forum where management of complex hematological cases can be discussed amongst physicians practicing mainly hematology malignancies and disorders, so that consistency is achieved for better outcomes
Indy Hematology Review Weekend
DRIVE Meeting
March 6, 2026
This symposium convenes oncology professionals, researchers, and policy advocates to explore the current challenges and strategic solutions in advancing inclusive excellence across the cancer research continuum. Attendees will engage with thought leaders discussing policy-aligned models for accountability, tools for building diversity plans into clinical trial design, and methods for standardizing demographic reporting in academic publications.
With a focus on practical implementation, the DRIVE Initiative offers a blueprint to help institutions, sponsors, and investigators align with regulatory guidance, such as the U.S. FDORA Act of 2022, while advocating for its broader international adoption. This is more than an academic discussion; it's a call to action for stakeholders committed to advancing equitable outcomes in cancer care and research.
CONCERT Network
March 6, 2026
A free, half day of presentations for community oncologists, preceding our annual “Indy Hematology Review”.
Innovative immune effector therapies, including CAR T-cell and bi-specific antibody treatments, have transformed cancer care but remain largely inaccessible to community oncology practices. Our NETWORK is dedicated to bridging this gap by establishing the necessary infrastructure, protocols, and training to safely and effectively administer these lifesaving therapies in community settings. By promoting equitable access, fostering clinical trial participation, and supporting diverse patient populations, we aim to reduce disparities and expand the reach of modern cellular therapies.
IHE Rising Stars
March 6, 2026
The purpose of this is to invite trainees in medical oncology and hematology from across the nation to attend our conference and to have access to our esteemed international faculty. The goal of our conference is to promote education, interaction, networking, and an opportunity to look toward the future including potential employment for our trainees. IHE will be providing an overnight room to fellows in order to facilitate the ability of our trainees to attend this conference.
Indy Hematology Review
March 7, 2026
Join us in Indianapolis for a full day of presentations by the nation’s top experts in Hematology and Hematologic Malignancies. Participants will have the opportunity to interact with these thought leaders in several panel discussions. This annual hematology review is one of the most comprehensive, educational hematology conferences in the country. Our exceptional faculty will provide a concise and practical summary of the American Society of Hematology annual meeting, presenting the most current hematology research and clinical practice.
Quarterly Dinner
Indy Hematology Clinical Rounds
April 22, 2026
In pursuant of promoting education in hematologic malignancies and disorders, Dr. Ruemu Ejedafeta Birhiray, President and CEO of Indy Hematology Education, Inc, in collaboration with Dr’s. Sumeet Bhatia and Catherine Socec, co- chair “Indy Hematology Clinical Rounds®” a quarterly CME education program.
This program is to create a tumor board forum where management of complex hematological cases can be discussed amongst physicians practicing mainly hematology malignancies and disorders, so that consistency is achieved for better outcomes